IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1714 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (95 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article

 Article Access Statistics
    Viewed2428    
    Printed43    
    Emailed0    
    PDF Downloaded104    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 


 
SEMINAR: CHRONIC ARSENICOSIS IN INDIA
Year : 2008  |  Volume : 74  |  Issue : 6  |  Page : 558

From the desk of the guest editor


Department of Dermatology, IPGME&R, Kolkata, India

Correspondence Address:
Sujit Ranjan Sengupta
Department of Dermatology, IPGME&R, Kolkata
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.45096

Rights and Permissions



How to cite this article:
Sengupta SR. From the desk of the guest editor. Indian J Dermatol Venereol Leprol 2008;74:558

How to cite this URL:
Sengupta SR. From the desk of the guest editor. Indian J Dermatol Venereol Leprol [serial online] 2008 [cited 2019 Oct 20];74:558. Available from: http://www.ijdvl.com/text.asp?2008/74/6/558/45096


When the world is going crazy managing HIV/AIDS, another silent killer is preparing itself to mount its attack on the mankind. Arsenicosis is the name of the emerging threat and dermatologists play a key role in case detection and subsequent management. The skin manifestations are pathognomonic and diagnosis can be reached by a meticulous dermatological examination even in the absence of laboratory facilities to detect the arsenic levels.

The situation of arsenicosis is getting worse with each passing year. India and Bangladesh are among the worst affected countries and they don't even have the setup to follow the WHO's guideline (<10 mg/L) of detection of arsenic level in drinking water. The source of arsenic consumption is not limited to drinking water but even beverages, milk, crops and vegetables grown on arsenic contaminated water are found to be responsible, apart from industrial pollutants.

Arsenicosis is not just limited to the skin but has profound and protean systemic manifestations. The morbidity associated with the disease is immense and it also leads to social ostracism. Systemic or skin malignancies arising secondary to arsenicosis have significant mortality. Unfortunately, till date no satisfactory treatment is available for reverting the clinical damages once produced. Hence, increasing awareness of the society and medical community towards this health hazard is an important step in the fight against arsenicosis. I am happy that IJDVL has decided to join this fight by publishing this unique symposium on a subject that is relevant to India.



This article has been cited by
1 Arsenic-Associated Changes to the Epigenome: What Are the Functional Consequences?
Kathryn A. Bailey,Rebecca C. Fry
Current Environmental Health Reports. 2014;
[Pubmed] | [DOI]
2 The evolving use of arsenic in pharmacotherapy of malignant disease
Athena Kritharis,Thomas P. Bradley,Daniel R. Budman
Annals of Hematology. 2013; 92(6): 719
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow